<DOC>
	<DOCNO>NCT00126477</DOCNO>
	<brief_summary>RATIONALE : Studying quality life cancer survivor may help determine long-term effect hematologic cancer may help improve quality life future cancer survivor . PURPOSE : This clinical trial study quality life adult cancer survivor undergo previous bone marrow peripheral stem cell transplant childhood hematologic cancer .</brief_summary>
	<brief_title>Quality Life Adult Cancer Survivors Who Have Undergone Previous Bone Marrow Peripheral Stem Cell Transplant Childhood Hematologic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine extent adult cancer survivor undergo prior bone marrow peripheral blood stem cell transplantation pediatric hematologic malignancy require ongoing health care whether need change increase time transplantation . - Correlate physical capability , body image , physical limitation , include sexuality issue alter influence lifestyle , time transplantation patient . - Determine whether cognitive ability relative memory neurobehavioral rating change increase time transplantation patient . - Correlate social relationship ability length time transplantation patient . OUTLINE : Patients sibling complete self-report quality life questionnaire , include outcome assessment neuroendocrine function , cognitive ability , physical capability , psychosocial behavior . PROJECTED ACCRUAL : Approximately 750 patient ( 375 adult cancer survivor [ case group ] 375 sibling [ control group ] ) accrue study within 7 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Case group Previously treat allogeneic , unrelated , syngeneic , autologous bone marrow peripheral blood stem cell transplantation hematologic malignancy â‰¥ 5 year ago enrol 1 follow protocol : FHCRC160.06 FHCRC179.07T FHCRC446.03T FHCRC661.04 FHCRC697.00 FHCRC796.00 FHCRC843.00 Diseasefree survivor Under 18 year age time transplantation Any prior preparative regimen allow Control group Sexmatched sibling within 5 year patient 's age* No chronic illness ( e.g. , cancer , diabetes , asthma ) require medication No allergies limit physical activity NOTE : *If sibling available , another sibling available , sibling would ask nominate friend relative gender patient also within 5 year patient 's age ; patient must consent order control subject participate PATIENT CHARACTERISTICS : Age See Disease Characteristics 18 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Must able speak , read , write English PRIOR CONCURRENT THERAPY : Biologic therapy See Disease Characteristics Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>quality life</keyword>
	<keyword>de novo myelodysplastic syndrome</keyword>
	<keyword>previously treat myelodysplastic syndrome</keyword>
	<keyword>secondary myelodysplastic syndrome</keyword>
	<keyword>juvenile myelomonocytic leukemia</keyword>
	<keyword>childhood Hodgkin lymphoma</keyword>
	<keyword>childhood lymphoblastic lymphoma</keyword>
	<keyword>childhood large cell lymphoma</keyword>
	<keyword>childhood small noncleaved cell lymphoma</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>childhood acute myeloid leukemia remission</keyword>
	<keyword>childhood chronic myelogenous leukemia</keyword>
</DOC>